{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:13:12Z","timestamp":1789215192001,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.prro.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T11:40:04Z","timestamp":1658749204000},"page":"e45-e53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Practical Workflow for Magnetic Resonance\u2013Guided Stereotactic Body Radiation Therapy to the Pancreas"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-4347","authenticated-orcid":false,"given":"Austin J.","family":"Sim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Hoffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kujtim","family":"Latifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell F.","family":"Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Feygelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Leuthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Dookhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Frakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2022.07.001_bib0001","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA Oncol"},{"issue":"3 suppl","key":"10.1016\/j.prro.2022.07.001_bib0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/JCO.2021.39.3_suppl.377","article-title":"Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas","volume":"39","author":"Katz","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0003","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoncol.2021.0057","article-title":"Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer","volume":"7","author":"Reyngold","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0005","article-title":"Ablative five-fraction stereotactic body radiation therapy for inoperable pancreatic cancer using online mr-guided adaptation","volume":"6","author":"Hassanzadeh","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"6","key":"10.1016\/j.prro.2022.07.001_bib0006","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/PPO.0000000000000292","article-title":"Ablative radiotherapy doses for locally advanced: pancreatic cancer (LAPC)","volume":"23","author":"Crane","year":"2017","journal-title":"Cancer J"},{"key":"10.1016\/j.prro.2022.07.001_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-9-11","article-title":"Adequacy of inhale\/exhale breathhold CT based ITV margins and image-guided registration for free-breathing pancreas and liver SBRT","volume":"9","author":"Yang","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0008","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.prro.2019.11.005","article-title":"Pancreas SBRT: Who, what, when, where, and how\u2026","volume":"10","author":"Bernard","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0009","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijrobp.2013.02.022","article-title":"Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated","volume":"86","author":"Chuong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.07.001_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-019-1275-3","article-title":"Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: State of the art, pearls and pitfalls","volume":"14","author":"Boldrini","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0011","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncology"},{"key":"10.1016\/j.prro.2022.07.001_bib0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prro.2020.09.005","article-title":"Ablative 5-fraction stereotactic magnetic resonance-guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable pancreas cancer","volume":"11","author":"Chuong","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0013","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/cam4.2100","article-title":"Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer","volume":"8","author":"Rudra","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.prro.2022.07.001_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.842402","article-title":"Stereotactic MR-guided radiotherapy for pancreatic tumors: Dosimetric benefit of adaptation and first clinical results in a prospective registry study","volume":"12","author":"Michalet","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/toxsci\/kfaa021","article-title":"Reducing the toxicity of radiotherapy for pancreatic cancer with magnetic resonance-guided radiotherapy","volume":"175","author":"Tchelebi","year":"2020","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.prro.2022.07.001_bib0016","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ijrobp.2021.05.172","article-title":"Improving the MR-guided radiotherapy patient experience through story driven video with 3D animations","volume":"111","author":"Linkowski","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.07.001_bib0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.prro.2022.01.005","article-title":"Location, location, location: What should be targeted beyond gross disease for localized pancreatic ductal adenocarcinoma (PDAC)? Proposal of a standardized clinical tumor volume (CTV) for PDAC of the head: The \"Triangle Volume","volume":"12","author":"Hill","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/COC.0000000000000518","article-title":"Pattern of marginal local failure in a phase II trial of neoadjuvant chemotherapy and stereotactic body radiation therapy for resectable and borderline resectable pancreas cancer","volume":"42","author":"Kharofa","year":"2019","journal-title":"Amer J Clin Onco"},{"key":"10.1016\/j.prro.2022.07.001_bib0019","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.prro.2019.06.016","article-title":"Radiation therapy for pancreatic cancer: Executive summary of an ASTRO clinical practice guideline","volume":"9","author":"Palta","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2020.07.052","article-title":"ESTRO ACROP guidelines for target volume definition in pancreatic cancer","volume":"154","author":"Brunner","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.07.001_bib0021","doi-asserted-by":"crossref","unstructured":"Jethwa KR, Neibart SS, Truty MJ, Jabbour SK, Hallemeier CL. Patterns of recurrence after primary local therapy for pancreatic ductal adenocarcinoma: A critical review of rationale and target delineation for (neo)adjuvant radiation therapy. Pract Radiat Oncol. doi:10.1016\/j.prro.2022.06.004, Accessed May 6, 2022.","DOI":"10.1016\/j.prro.2022.06.004"},{"key":"10.1016\/j.prro.2022.07.001_bib0022","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijrobp.2021.07.1698","article-title":"Pancreatic stereotactic body radiation therapy with or without hypofractionated elective nodal irradiation","volume":"112","author":"Miller","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.07.001_bib0023","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.zemedi.2018.02.002","article-title":"A practical implementation of physics quality assurance for photon adaptive radiotherapy","volume":"28","author":"Cai","year":"2018","journal-title":"Z Med Phys"},{"issue":"8","key":"10.1016\/j.prro.2022.07.001_bib0024","first-page":"e1618","article-title":"Online adaptive radiation therapy: Implementation of a new process of care","volume":"9","author":"Lamb","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.prro.2022.07.001_bib27","unstructured":"Applied Radiation Oncology. FDA clears MRIdian A3i radiation therapy features announced at ASTRO. Available at. June 24, 2022. https:\/\/www.appliedradiationoncology.com\/articles\/fda-clears-mridian-a3i-radiation-therapy-features-announced-at-astro Accessed October 11, 2022."},{"key":"10.1016\/j.prro.2022.07.001_bib0026","doi-asserted-by":"crossref","first-page":"e4454","DOI":"10.1002\/nbm.4454","article-title":"Heterogeneity analysis of MRI T2 maps for measurement of early tumor response to radiotherapy","volume":"34","author":"Tomaszewski","year":"2021","journal-title":"NMR Biomed"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022002090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022002090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:24:02Z","timestamp":1761819842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850022002090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1879850022002090"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2022.07.001","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Practical Workflow for Magnetic Resonance\u2013Guided Stereotactic Body Radiation Therapy to the Pancreas","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}